These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9741938)

  • 1. Targeted delivery of plasmid DNA complexed with galactosylated poly(L-lysine).
    Hashida M; Takemura S; Nishikawa M; Takakura Y
    J Control Release; 1998 Apr; 53(1-3):301-10. PubMed ID: 9741938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted delivery of plasmid DNA to hepatocytes in vivo: optimization of the pharmacokinetics of plasmid DNA/galactosylated poly(L-lysine) complexes by controlling their physicochemical properties.
    Nishikawa M; Takemura S; Takakura Y; Hashida M
    J Pharmacol Exp Ther; 1998 Oct; 287(1):408-15. PubMed ID: 9765363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and in vivo gene transfer of plasmid DNA complexed with mannosylated poly(L-lysine) in mice.
    Nishikawa M; Takemura S; Yamashita F; Takakura Y; Meijer DK; Hashida M; Swart PJ
    J Drug Target; 2000; 8(1):29-38. PubMed ID: 10761643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(L-lysine).
    Mahato RI; Takemura S; Akamatsu K; Nishikawa M; Takakura Y; Hashida M
    Biochem Pharmacol; 1997 Mar; 53(6):887-95. PubMed ID: 9113108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes.
    Mahato RI; Kawabata K; Nomura T; Takakura Y; Hashida M
    J Pharm Sci; 1995 Nov; 84(11):1267-71. PubMed ID: 8587040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-mediated gene transfer to cells of hepatic origin by galactosylated albumin-polylysine complexes.
    Han J; Lim M; Yeom YI
    Biol Pharm Bull; 1999 Aug; 22(8):836-40. PubMed ID: 10480322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition characteristics of plasmid DNA in the single-pass rat liver perfusion system.
    Yoshida M; Mahato RI; Kawabata K; Takakura Y; Hashida M
    Pharm Res; 1996 Apr; 13(4):599-603. PubMed ID: 8710753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on galactose-poly(ethylene glycol)-poly(L-lysine) as novel gene vector for targeting hepatocytes in vitro.
    Hu HM; Zhang X; Zhong NQ; Pan SR
    J Biomater Sci Polym Ed; 2012; 23(5):677-95. PubMed ID: 21375808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor-mediated transfer of DNA--galactosylated poly-L-lysine complexes into mammalian cells in vitro and in vivo.
    Dizhe EB; Akifiev BN; Missul BV; Orlov SV; Kidgotko OV; Sukonina VE; Denisenko AD; Perevozchikov AP
    Biochemistry (Mosc); 2001 Jan; 66(1):55-61. PubMed ID: 11240393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-mediated gene delivery and expression in vivo.
    Wu GY; Wu CH
    J Biol Chem; 1988 Oct; 263(29):14621-4. PubMed ID: 3049582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a targeted gene carrier, lactose-polyethylene glycol-grafted poly-L-lysine and its complex with plasmid DNA.
    Choi YH; Liu F; Choi JS; Kim SW; Park JS
    Hum Gene Ther; 1999 Nov; 10(16):2657-65. PubMed ID: 10566893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition characteristics of glycosylated poly(amino acids) as liver cell-specific drug carrier.
    Akamatsu K; Imai M; Yamasaki Y; Nishikawa M; Takakura Y; Hashida M
    J Drug Target; 1998; 6(3):229-39. PubMed ID: 9888309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palmitic acid-modified poly-L-lysine for non-viral delivery of plasmid DNA to skin fibroblasts.
    Abbasi M; Uludag H; Incani V; Olson C; Lin X; Clements BA; Rutkowski D; Ghahary A; Weinfeld M
    Biomacromolecules; 2007 Apr; 8(4):1059-63. PubMed ID: 17335285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes.
    Managit C; Kawakami S; Yamashita F; Hashida M
    J Pharm Sci; 2005 Oct; 94(10):2266-75. PubMed ID: 16136555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system.
    Nishikawa M; Yamauchi M; Morimoto K; Ishida E; Takakura Y; Hashida M
    Gene Ther; 2000 Apr; 7(7):548-55. PubMed ID: 10819569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution and anti-HBV effects of antisense oligodeoxynucleotides conjugated to galactosylated poly-L-lysine.
    Zheng SJ; Zhong S; Zhang JJ; Chen F; Ren H; Deng CL
    World J Gastroenterol; 2003 Jun; 9(6):1251-5. PubMed ID: 12800234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-tapgeted gene carrier.
    Choi YH; Liu F; Park JS; Kim SW
    Bioconjug Chem; 1998; 9(6):708-18. PubMed ID: 9815164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake.
    Kawabata K; Takakura Y; Hashida M
    Pharm Res; 1995 Jun; 12(6):825-30. PubMed ID: 7667185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo gene delivery to the liver using novel galactosylated cationic liposomes.
    Kawakami S; Fumoto S; Nishikawa M; Yamashita F; Hashida M
    Pharm Res; 2000 Mar; 17(3):306-13. PubMed ID: 10801219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic glycopeptide-based delivery systems for systemic gene targeting to hepatocytes.
    Anwer K; Logan M; Tagliaferri F; Wadhwa M; Monera O; Tung CH; Chen W; Leonard P; French M; Proctor B; Wilson E; Singhal A; Rolland A
    Pharm Res; 2000 Apr; 17(4):451-9. PubMed ID: 10870990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.